News >

Can Biosimilars Help Control Rising Drug Costs?

Caroline Seymour
Published: Thursday, Nov 21, 2019

Lee S. Schwartzberg,
MD

Lee S. Schwartzberg, MD
Biosimilars are slated to become a fixture of treatment in oncology due to their cost-savings potential, explained Lee S. Schwartzberg, MD, FACP, executive director of West Cancer Center.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x